* New tools for biomarker-discovery * Endophenotype strategy * Peripheral biomarkers for neuropsychiatric disorders * Neuroimaging biomarkers and endophenotypes * Neurocognitive biomarkers and endophenotypes * Pharmacogenetics and pharmacogenomics Neuropsychiatric disorders such as schizophrenia, mood disorders, Alzheimervesque, and Claude RouillardAfterword by Robert H. BelmakerContents of Volumes 1, 2, and 3Contributors of Volumes 1, 2, and 3Index